Centene (NYSE:
CNC) is upgraded from Underperform to Outperform at Oppenheimer. The analysts raised their price target on Centene from $18 to $28.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
